Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Treatment for breast cancer essay
Treatment for breast cancer essay
Treatment for breast cancer essay
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Treatment for breast cancer essay
Introduction
In 2008, there were approximately 1,380,000 cases of female breast cancer worldwide (1, 2). According to the American Society of cancer the trend of female breast cancer are increasing. The approximate number of female breast cancer in US in 2013 was 232,340 cases (account for 29% of all female cancer in US) (3). In Thailand, there was approximate number of 12,000 new female breast cancer cases per year (4). Thus breast cancer is still one of the most important female cancers.
It is a consensus that breast cancer is systemic disease. Multimodality treatment is needed to cure from the residual cancer after the surgery (5-11). Three well established systemic treatments for breast cancer are chemotherapy, hormonal therapy, and biological targeted therapy. Systemic chemotherapy claims to have high effective against breast cancer, but it can cause serious side effects in the patients (12, 13). Unlike chemotherapy, hormonal treatment (one of biological targeted therapy) has fewer side effects, but the tumors need to express hormonal receptors in their cells (8, 14). Up to date, there are two kinds of hormonal treatment for breast cancer; anti-estrogen receptor drug (eg. Tamoxifen) (15-17) and aromatase inhibitors (eg. Letrozole) (10, 18, 19). Biological targeted therapy is a new way to flight against breast cancer, but the cost is still very high. Even the effective systemic treatment, breast cancer still has the high death rate. According to US cancer fact sheet death rate was about one-fifth of the cases in 2013 (3).
The morbidity and mortality is higher in triple negative breast cancer, which is hormonal receptors negative ontology (20, 21). Chemotherapy and biological targeted therapy are two systemic tr...
... middle of paper ...
... advance stage breast cancer as study by de Matteis, et al. and Scholl A. (41, 42) or treat skin metastasis by Battelli, et al.(43). Androgen may be a new target for breast cancer treatment on the future (44).
Conclusion
The prevalence of androgen receptors in Thai breast cancer patients was 80.00% and less expression in triple negative breast cancer patients (33.33%). The androgen may be a new target therapy for Thai breast cancer patients who had highly expressed of androgen receptors. The Thai triple negative breast cancer had lower androgen expression than previously report by western countries. The hormonal status (ER/PR) was strongly related to the androgen receptor expression; on the opposite way, triple negative ontology trend to had lower androgen receptor expression. For this finding, androgen expression may relate to the prognosis of the breast tumors.
Breast cancer is one of the most common and important diseases that affect women and ovarian cancer is the fourth most common cause of cancer mortality in American women1. These cancers are triggered by germline mutations on the C-terminal of a gene called BRCA1 (or “Breast Cancer 1, Early Onset Gene”) tumor suppressor. The BRCA1 gene is located on the long (q) arm of chromosome 17 at region 2 band 1, consists of 24 exons and encodes a multidomain protein of 1863 amino acid residues in human2. The BRCA1 proteins produced from BRCA1 gene help preventing cells from growing and dividing too rapidly or in an uncontrolled way3. The family of BRCA1 genes is called RING-type zinc fingers or RNF. The BRCA1 protein is characterized within the superfamily of Rad9-like proteins which consist of C-terminal BRCT repeats that assist in the binding of phosphorylated proteins in the DNA damage response and DNA repair4. Like many other genes involved in familial cancer, BRCA1 appears to encode a tumor suppressor, a protein that acts as a negative regulator of tumor growth1. BRCA1 proteins are important in genomic stability so loss of their function can cause genetic instability which lead to tumourigenesis. Thus, the sequence of BRCA1 protein is analyzed to the understanding the protein’s function in the development of the cancers.
..., t. t. (n.d.). Menopausal Hormone Replacement Therapy Use and Cancer - National Cancer Institute. Comprehensive Cancer Information - National Cancer Institute. Retrieved September 19, 2011, from http://www.cancer.gov/cancertopics/factsheet/Risk/menopausal-hormones/print
Over the past decade breast cancer has become one of the most predominant diseases in the United States. Breast cancer starts out as a malignant tumor in the tissues of the breast which is formed from the uncontrolled growth of abnormal breast cells. Breast cancer is the most common cancer in women, but it can also appear in men. (Stephan, 2010)
Breast cancer is most commonly diagnosed in Stage I and Stage II, where the size of the tumor is less than five centimeters in diameter. In these situations, surgery is often the second treatment option after chemotherapy and radiation therapy, both of which are used to shrink the tumor to a manageable size first. If the patient chooses to, the ...
In 1896 the scientist Beatson reported that the removal of the ovaries resulted in the reduction of breast cancer tumours (Russo and Irma 1998). Breast cancer is a malignant, metastasizing cancer of the mammary gland. It is the leading cause of death in woman between the ages of 35 - 45. Breast cancer can also occur in males, although less frequent, around 400 men die each year from breast cancer in the united states. (Martini, F., 2004). Studies on rats have shown considerable evidence that rat oestrogens are mammary carcinogens. Oestrogens have shown to stimulate the hormone prolactin. Through studies involving the use of antioestrogens, for example, tamoxifen, "Tamoxifen alone or in combination with the retina all trans-N-(4 hydroxyphenyl)-retinamide (4-HPR) reduces the incidence of NMU-induced mammary tumours in Sprague-Dawley rats." (Jane M. Ussher Ph.D. 1996). This suggests that Oestrogens and Prolactin's can have the effect of the development of breast cancer since the pathogenesis of spontaneous breast cancer in humans is similar to that of chemical-induced rodent mammary cancer. (Jane M. Ussher
...ars to be the most promising agent in primary prevention of breast cancer. It changed the way prevention is perceived by biomedicalizing it. Prevention is seen as equivalent to risk reduction. Also, it is the only United States Food and Drug Administration (US FDA) approved drug for reducing breast cancer risk in high-risk women. Promising as it may seem, the scope of primary prevention has been restricted to women at high risk of developing breast cancer because of inherent limitations of these strategies. Knowledge is power, “The lack of knowledge in the realm of breast cancer prevention makes for greater investment in chemoprevention”. Owing to failure of etiologic studies in breast cancer research to identify primary prevention strategies suitable for the general population, reducing mortality through early detection of breast cancer still remains the mainstay.
Many breast cancers are sensitive to the hormone estrogen. Thus estrogen leads to development of breast cancer tumor formation. Such cancers have cell surface receptors for estrogen. They are called ER-positive cancer or estrogen receptor-positive cancer.
Breast Cancer is a disease that can sometime lead to ovarian cancer and has caused a lot of women’s death. “About five to ten percent of breast cancer cases are thought to be hereditary, meaning that they result from gene defects called mutations inherited from a parent”. Related Risks early menstruation, oral contraceptives and child bearing 20 percent. (1)An environmental risk is that toxins can damage breast DNA. Over time damaged DNA can lead to cancer. Your risk of developing breast cancer increases as you get older. “1 of 8 breast cancer are found when women are younger than 45. 2 of 3 breast cancer are found in women age 55 years or older 75 percent greater chance”.(1) Breast Cancer can lead Peutz Jeghers syndrome the effects of Peutz Jeghgers is spots on your lips and in their mouths. Women with no children or who had a child after age 30 have slightly higher breast cancer risk. “Screening for breast cancer is early diagnosis increases chance of survival and annual mammogram after age 40”. Women who took Diethylstilbestrol while pregnant could have a slightly higher risk of developing breast cancer. Birth control peals also cause higher risks 40 to 50 percent for breast cancer risk calms down after they have stopped taking them.(1) Using combined hormone therapy after menopause increase the risk of getting breast cancer , it also increase women chances of dying from it. If you are over weight or obese after menopause greatly increase breast cancer risk 20 percent. Drinking alcohol can cause a major effect for you to start developing breast cancer the risk increase the more you drink. Tobacco smoke, Night work, Antiperspirants, Bras and Induced abortion. Breast cancer takes a lot of toll on women and men of all races and...
Androgen insensitivity syndrome (AIS) is a genetic X-linked recessive disorder where affected males have mostly female sex characteristics or signs of both male and female sexual development. Individuals with this condition are genetically male; they contain both an X and Y chromosome (Barbaro et al., 2007). Mutations in the androgen receptor gene are what cause androgen insensitivity syndrome in individuals. This gene produces androgen receptors which are important to males. Without this receptor androgen will not be supplied to the body and that is a major hormone males need. Other names used in place of AIS are as follows; Testicular Feminization Syndrome (TFM), Androgen Receptor Deficiency, Androgen Resistance Syndrome, AR Deficiency, Dihydrotestosterone Receptor Deficiency, and DHTR Deficiency (OMIM, 2012). Androgen insensitivity syndrome can be considered as complete androgen insensitivity syndrome, partial androgen insensitivity syndrome, or mild androgen insensitivity syndrome.
About 12% of women in the United States will develop breast cancer in their lifetime, more than any other type of cancer (www.breastcancer.org, 2015). Many people lack the knowledge of how breast cancer is developed. Some people think they will not get cancer because they do not smoke cigarettes, but this is not the only cause of cancer developing in the breast. Anyone can get cancer. Everyone is potentially at risk for developing some form of Cancer (American Cancer Society, 2015).
Transmed Network. (1997). Breast Cancer-Genetic Epidemiology. Retrieved November 19, 2000 from the World Wide Web: http://www.breastdiseases.com/genebr2.htm
Breast Cancer is defined as “a group of solid tumor malignancies arising in the tissues of the breast” (Sarah Crawford, Richard Alder, 2013) in human and other mammals. It can happen to both men and women. For women, breast cancer is one of the leading causes of cancer death. According to National Cancer Institute, in the United States, the 2014 estimated new cases and deaths of female from breast cancer are 232,670 and 40,000, respectively. For male, it’s 430 deaths out of 2,360 new cases. From these numbers, we can see that women in the U.S. are greatly affected by breast cancer, thus, it’s not difficult to imagine the impact on a worldwide level. Although these numbers look frightening, people can actually survive from breast cancer if it is detected early and treated properly, so it is extremely important for all of us, especially women, to have a better understanding of breast cancer.
Rosen, Leo and Rosen, Gloria. (2011).Learn About Cancer. American Cancer Society. Retrieved November 26, 2015 from http://www.cancer.org/cancer/breastcancer/index
There are different types of stages of breast cancer. Staging tells how far the cancer has spread within the body, staging is determined after breast cancer has been diagnosed and stages from 0 to 4 depending on how far its spread. Stage 0 cancer cells are only found in one location, Stage I cancer cells have left the milk ducts but haven’t reached the lymph nodes, Stage II cancer increases in size and has reached the armpit lymph nodes, Stage III cancer has spread to the cervical lymph nodes or tissue around the breast, Stage IV cancer has spread to other organs. Treatments are Herceptin witch cause cells to die, Kadcyla a cell killing drug let into the cancer cells, Tykerb and Perjeta. All these treatments have side effects.
A research was held for young and older women. Two drugs were administered to treat breast cancer. Epirubicin and gemcitabine are two chemotherapy drugs used on the patients. The research came back with astonishing results. The Young and older women had a positive reaction to the drugs. Dr. Feher’s research shows the drug to be safe enough for young women and the older generation to treat breast cancer (Dockter & Keene, 2009).